Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 2,021.30
-41.90 (-2.03%)
At close: Sep 16, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 335.4 billion as of September 16, 2026. Its market cap has increased by 35.97% in one year.
Market Cap
335.40B
Enterprise Value
355.00B
Revenue
36.53B
Ranking
n/a
PE Ratio
82.00
Stock Price
2,021.30
ChartMarket Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 335.40B, an increase of 1,827.17%. That is a compound annual growth rate of 12.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 335.40B | 42.73% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 967.09B |
| Lupin | 958.36B |
| Abbott India | 543.69B |
| GlaxoSmithKline Pharmaceuticals | 480.64B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 225.41B |
| Caplin Point Laboratories | 209.39B |
| AstraZeneca Pharma India | 169.63B |